SCHEMBL15073455

SCHEMBL15073455

COc1ccc(/N=C(\Cc2ccccc2)c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.55
KDM4E B2RXH2 1/20 0.55
PKM P14618 2/20 0.49
MGLL Q99685 1/20 0.48
THRB P10828 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LTA4H P09960 1/20 0.47
PLAU P00749 1/20 0.47
ELANE P08246 1/20 0.47
ALDH1A1 P00352 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 1/20 0.47
NOS3 P29474 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR3A P46098 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
NPC1 O15118 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16336153 1.00 SMN1; SMN2 (0.55) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL16336154 1.00 SMN1; SMN2 (0.55) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL15073451 0.97 SMN1; SMN2 (0.59) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL16336372 0.97 SMN1; SMN2 (0.59) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL16336373 0.97 SMN1; SMN2 (0.59) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL16382903 0.91 SMN1; SMN2 (0.54) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL15073434 0.90 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL16336149 0.90 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL16336148 0.90 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EPKMMGLLTHRB
SCHEMBL6369259 0.83 CTSL (0.51) PLAUMAPTNOS3HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334275-B2 Processes for preparing indoles NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-05-10 US disclosed
US-9334275-B2 Processes for preparing indoles NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-05-10 US disclosed
US-20150005494-A1 PROCESSES FOR PREPARING INDOLES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-01-01 US disclosed
US-20150005494-A1 PROCESSES FOR PREPARING INDOLES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-01-01 US disclosed
WO-2013095304-A1 PROCESSES FOR PREPARING INDOLES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005494-A1 PROCESSES FOR PREPARING INDOLES IDO1, INMT, IDO2 SMN1; SMN2 2546/4885KDM4E 2552/4885PKM 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.